Pituitary Tumors Induced by Estrogen, Rat
As early as 1 month after intramuscular administration of estrogen (Teikokuzoki Co., Ltd.) at the rate of 5 mg/rat/month, the pituitary gland becomes hyperplastic. At this stage, the pituitary gland is enlarged to 2–3 times its normal size and is usually white to tan. Six months after the start of the estrogen injections the gland is tumorous, markedly congested, and enlarged up to tenfold. The tumor mass is well encapsulated and does not invade the adjacent tissue. The intermediate lobe is difficult to distinguish at this stage.
KeywordsPituitary Gland Secretory Granule Intermediate Lobe Growth Hormone Cell Estrogen Injection
Unable to display preview. Download preview PDF.
- Furth J, Clifton K (1966) Experimental pituitary tumors. In: Harris GW, Donovan BT (eds) The pituitary gland. Butter-worths, London vol 2, pp 460–497Google Scholar
- Furth J, Nakane P, Pasteels JL (1976) Tumours of the pituitary gland. In: Turusov VS (ed) Pathology of tumours in laboratory animals. vol I Tumours of the rat. IARC Scientific Publ. 466, Lyon Part 2 pp 201–237Google Scholar
- Osamura RY, Watanabe K (1976) Peroxidase-labeled antibody method: its principle and applications to endocrinology. Clin Endocrinol 24: 1074–1087Google Scholar
- Osamura RY, Komatsu N, Izumi S, Yoshimura S, Murakoshi M, Watanabe K (1981) Pre-embedding immunoelectron microscopy by peroxidase-labeled antibody method. Applications to endocrinology. Acta Histochem Cytochem 14: 383–390Google Scholar